Molnlycke Health Care

Two Omega Drive, Irlam, Manchester, M44 5BJ , UK
Telephone: +44 (0)161 777 2600
Fax: +44 (0)161 777 2601
WWW: http://www.molnlycke.com
Medical Information Direct Line: +44 (0)161 777 2628
Medical Information e-mail: ukmedical.information@molnlycke.com
Customer Care direct line: +44 (0)161 777 2600
Medical Information Fax: +44 (0)161 621 2045


Summary of Product Characteristics last updated on the eMC: 20/09/2006
SPC Betadine Gargle & Mouthwash


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Betadine Gargle and Mouthwash.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Povidone Iodine USP 1% w/v (equivalent to 0.1% w/v of available iodine).


Go to top of the page
3. PHARMACEUTICAL FORM

Solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the treatment of acute mucosal infections of the mouth and pharynx, for example gingivitis, and mouth ulcers. For oral hygiene prior to, during and after dental and oral surgery.


Go to top of the page
4.2 Posology and method of administration

For oral administration, as a gargle and mouthwash. The product should not be swallowed. Adults and children over 6 years of age: Use undiluted or diluted with an equal volume of warm water. Gargle or rinse with up to 10ml for up to 30 seconds without swallowing. Repeat up to four times daily, for up to 14 consecutive days, or as directed.


Go to top of the page
4.3 Contraindications

Not for use in children under 6 years of age and in patients with a known or suspected iodine hypersensitivity. Regular use is contraindicated in patients and users with thyroid disorders (in particular nodular colloid goitre, endemic goitre and Hashimoto's thyroiditis).


Go to top of the page
4.4 Special warnings and precautions for use

Regular use should be avoided as prolonged use may lead to the absorption of a significant amount of iodine. Do not use for more than 14 days. If sores or ulcers in the mouth do not heal within 14 days, seek medical or dental advice. Regular use should be avoided in patients on concurrent lithium therapy.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Absorption of iodine from povidone iodine may interfere with thyroid function tests. Contamination with povidone iodine of several types of tests for the detection of occult blood in faeces or blood in urine may produce false-positive results.


Go to top of the page
4.6 Pregnancy and lactation

Regular use of povidone iodine should be avoided in pregnant or lactating women as absorbed iodine can cross the placental barrier and be secreted into breast milk. Although no adverse effects have been reported from limited use, caution should be recommended and therapeutic benefit must be balanced against possible effects of the absorption of iodine on foetal thyroid function and development. The use of Betadine Gargle and Mouthwash in pregnant and lactating women should be limited to a single treatment session only.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Idiosyncratic mucosal irritation and hypersensitivity reactions may occur. Excessive absorption of iodine may produce systemic effects such as metabolic acidosis, hypernatraemia and impairment of renal function.


Go to top of the page
4.9 Overdose

Excessive iodine can produce goitre and hypothyroidism or hyperthyroidism. Acute overdose may result in symptoms of metallic taste in the mouth, increased salivation, burning or pain in the throat or mouth, irritation and swelling in the eyes, difficulty in breathing due to pulmonary oedema, skin reactions, gastrointestinal upset and diarrhoea. Metabolic acidosis, hypernatraemia and renal impairment may occur. Treatment: In the cases of deliberate or accidental ingestion of large quantities of Betadine, symptomatic and supportive treatment should be provided with special attention to electrolyte balance and renal and thyroid function.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Betadine Gargle and Mouthwash contains povidone iodine, a complex of iodine which shows all the broad spectrum germicidal activity of elemental iodine. The germicidal activity is maintained in the presence of blood, pus, serum and necrotic tissue. Betadine Gargle and Mouthwash kills bacteria, viruses, fungi, spores and protozoa.


Go to top of the page
5.2 Pharmacokinetic properties

The product is intended for topical application to the mouth and buccal cavity.


Go to top of the page
5.3 Preclinical safety data

None stated.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Glycerol; menthol; methyl salicylate; ethanol 96%; saccharin sodium; purified water.


Go to top of the page
6.2 Incompatibilities

None stated.


Go to top of the page
6.3 Shelf life

36 months unopened.


Go to top of the page
6.4 Special precautions for storage

Store in a dry place below 25oC. Protect from light.


Go to top of the page
6.5 Nature and contents of container

Amber soda-lime-silica glass bottle (USP Type III) fitted with an externally ribbed white urea cap, with a steran faced wad or with a wadless polypropylene cap containing 250ml of product.


Go to top of the page
6.6 Special precautions for disposal and other handling

This product should not be swallowed.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Medlock Medical Limited, Tubiton House, Oldham, OL1 3HS.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 21248/0006.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

30th September 2005.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

September 2005.



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/1954/SPC/


Active Ingredients/Generics

 
   povidone iodine